share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dar Zavain

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dar Zavain

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Dar Zavain
美股sec公告 ·  06/05 18:17
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. (RXRX) reported that Dar Zavain, a person associated with the company, was granted 13,097 shares of Class A Common Stock on June 3, 2024. The transaction was completed at no cost to the recipient, indicating that the shares were likely awarded as part of a compensation package or incentive plan. Following this transaction, Zavain's direct holdings in the company increased to a total of 102,153 shares. The grant is part of the company's ongoing efforts to align the interests of its key personnel with those of its shareholders.
Recursion Pharmaceuticals, Inc. (RXRX) reported that Dar Zavain, a person associated with the company, was granted 13,097 shares of Class A Common Stock on June 3, 2024. The transaction was completed at no cost to the recipient, indicating that the shares were likely awarded as part of a compensation package or incentive plan. Following this transaction, Zavain's direct holdings in the company increased to a total of 102,153 shares. The grant is part of the company's ongoing efforts to align the interests of its key personnel with those of its shareholders.
Recursion Pharmaceuticals, Inc. (RXRX)報告指，與公司有聯繫的人——Dar Zavain在2024年6月3日獲得了13,097股A級普通股。該交易對接收方來說是沒有費用的，顯示這些股票可能作為償酬計劃或激勵計劃的一部分授予。此次交易後，Zavain在公司的持股總數增加到了102,153股。該授予是公司為了使關鍵人員的利益與股東的利益相一致而開展的持續努力之一。
Recursion Pharmaceuticals, Inc. (RXRX)報告指，與公司有聯繫的人——Dar Zavain在2024年6月3日獲得了13,097股A級普通股。該交易對接收方來說是沒有費用的，顯示這些股票可能作為償酬計劃或激勵計劃的一部分授予。此次交易後，Zavain在公司的持股總數增加到了102,153股。該授予是公司為了使關鍵人員的利益與股東的利益相一致而開展的持續努力之一。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息